Cargando…
Assessment of the safety of antimalarial drug use during early pregnancy (ASAP): protocol for a multicenter prospective cohort study in Burkina Faso, Kenya and Mozambique
BACKGROUND: A major unresolved safety concern for malaria case management is the use of artemisinin combination therapies (ACTs) in the first trimester of pregnancy. There is a need for human data to inform policy makers and treatment guidelines on the safety of artemisinin combination therapies (AC...
Autores principales: | Tinto, Halidou, Sevene, Esperança, Dellicour, Stephanie, Calip, Gregory S., d’Alessandro, Umberto, Macete, Eusébio, Nakanabo-Diallo, Seydou, Kazienga, Adama, Valea, Innocent, Sorgho, Hermann, Valá, Anifa, Augusto, Orvalho, Ruperez, Maria, Menendez, Clara, Ouma, Peter, Desai, Meghna, Ter Kuile, Feiko, Stergachis, Andy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4670540/ https://www.ncbi.nlm.nih.gov/pubmed/26637464 http://dx.doi.org/10.1186/s12978-015-0101-0 |
Ejemplares similares
-
First trimester use of artemisinin-based combination therapy and the risk of low birth weight and small for gestational age
por: Augusto, Orvalho, et al.
Publicado: (2020) -
First-trimester artemisinin derivatives and quinine treatments and the risk of adverse pregnancy outcomes in Africa and Asia: A meta-analysis of observational studies
por: Dellicour, Stephanie, et al.
Publicado: (2017) -
Dynamic of plasmodium falciparum chloroquine resistance transporter gene Pfcrt K76T mutation five years after withdrawal of chloroquine in Burkina Faso
por: Sondo, Paul, et al.
Publicado: (2015) -
Determinants of Plasmodium falciparum multiplicity of infection and genetic diversity in Burkina Faso
por: Sondo, Paul, et al.
Publicado: (2020) -
Genetically diverse Plasmodium falciparum infections, within-host competition and symptomatic malaria in humans
por: Sondo, Paul, et al.
Publicado: (2019)